119 related articles for article (PubMed ID: 9192545)
1. p53 In biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system.
De Araújo VC; Loyola AM; Pinto Júnior DD; Borra RC; De Araújo NS
Oral Oncol; 1997 Jan; 33(1):5-9. PubMed ID: 9192545
[TBL] [Abstract][Full Text] [Related]
2. Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma.
Albuquerque RL; Miguel MC; Costa AL; Souza LB
Int J Exp Pathol; 2003 Dec; 84(6):259-65. PubMed ID: 14748745
[TBL] [Abstract][Full Text] [Related]
3. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?
Lam KY; Law S; Ma LT; Ong SK; Wong J
Eur J Cancer; 1997 Jul; 33(8):1221-5. PubMed ID: 9301446
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas.
Koontongkaew S; Chareonkitkajorn L; Chanvitan A; Leelakriangsak M; Amornphimoltham P
Oral Oncol; 2000 Jul; 36(4):334-9. PubMed ID: 10899671
[TBL] [Abstract][Full Text] [Related]
9. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Löhrs U
Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
[TBL] [Abstract][Full Text] [Related]
10. Vimentin in oral squamous cell carcinoma.
de Araujo VC; Pinto Júnior DS; de Sousa SO; Nunes FD; de Araujo NS
Eur Arch Otorhinolaryngol; 1993; 250(2):105-9. PubMed ID: 7685179
[TBL] [Abstract][Full Text] [Related]
11. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in oral cancer: observations of a South Indian study.
Pillay M; Vasudevan DM; Rao CP; Vidya M
J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
[TBL] [Abstract][Full Text] [Related]
13. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.
Cruz I; Snijders PJ; Van Houten V; Vosjan M; Van der Waal I; Meijer CJ
J Clin Pathol; 2002 Nov; 55(11):834-40. PubMed ID: 12401821
[TBL] [Abstract][Full Text] [Related]
14. Evidence based demonstration of the concept of 'field cancerization' by p53 expression in mirror image biopsies of patients with oral squamous cell carcinoma - an immunohistochemical study.
Hande AH; Mohite DP; Chaudhary MS; Patel M; Agarwal P; Bohra S
Rom J Morphol Embryol; 2015; 56(3):1027-33. PubMed ID: 26662135
[TBL] [Abstract][Full Text] [Related]
15. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
[TBL] [Abstract][Full Text] [Related]
16. In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression.
Rosado P; Lequerica-Fernández P; Peña I; Alonso-Durán L; de Vicente JC
Virchows Arch; 2012 Aug; 461(2):163-8. PubMed ID: 22790665
[TBL] [Abstract][Full Text] [Related]
17. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
[TBL] [Abstract][Full Text] [Related]
18. Association between clinical stage of oral cancer and expression of immunohistochemical markers.
Świątkowski W; Rahnama M; Tomaszewski T; Bigas M; Świątkowska A; Łobacz M; Wallner J
Pol Przegl Chir; 2017 Dec; 89(6):17-22. PubMed ID: 29335388
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
20. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
